David Lee Johnson Global Blood Therapeutics, Inc. (GBT) insider trading activity

David Lee Johnson is Chief Commercial Officer of Global Blood Therapeutics, Inc.. Currently has a direct ownership of 0 shares of GBT, which is worth approximately $0. The most recent transaction as insider was on Feb 01, 2021, when has been sold 6,770 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

DAVID LEE JOHNSON Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 01 2021	BUY Exercise of conversion of derivative security	-	6,770 Added 18.67%	29,490 Common Stock
Oct 01 2020	SELL Payment of exercise price or tax liability	$125,773 $57.96 p/Share	2,170 Reduced 8.72%	22,720 Common Stock
Oct 01 2020	BUY Exercise of conversion of derivative security	-	4,375 Added 14.95%	24,890 Common Stock

Also insider at

CRBU

Caribou Biosciences, Inc. Healthcare

Director

VERA

Vera Therapeutics, Inc. Healthcare

Chief Operating Officer

DLJ